PAMS
ROIV icon

Pictet Asset Management (Switzerland)’s Roivant Sciences ROIV Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$384K Buy
38,079
+7,164
+23% +$64.1K ﹤0.01% 1378
2023
Q1 		$228K Hold
30,915
– – ﹤0.01% 1666
2022
Q4 		$247K Buy
30,915
+14,825
+92% +$82.5K ﹤0.01% 1611
2022
Q3 		$52K Hold
16,090
– – ﹤0.01% 1524
2022
Q2 		$65K Buy
+16,090
New +$63.9K ﹤0.01% 1519

Other funds holding ROIV

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PSC
Patient Square Capital Menlo Park, California $564M AUM 261.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s ROIV Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Roivant Sciences (ROIV) stake by 23% in Q2 2023, buying an estimated $64.1K and bringing the position to 38,079 shares worth $384K. The position accounts for ﹤0.01% of the portfolio, ranked #1378.

Pictet Asset Management (Switzerland) first reported a position in ROIV in Q2 2022 and has held it in 5 quarters since. 181 funds tracked by Wall St. Rank hold ROIV as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 38,079 shares of Roivant Sciences worth $384K as of Q2 2023.
  • Pictet Asset Management (Switzerland) bought 7,164 Roivant Sciences shares in Q2 2023, an estimated $64.1K.
  • Roivant Sciences made up ﹤0.01% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #1378 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Roivant Sciences in Q2 2022 and has held it in 5 quarters since.
  • 181 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.